Medical Polytetrafluoroethylene (PTFE) Market Reviewed for 2020 with Industry Outlook to 2027

Research Insights:

The versatility of PTFE materials has boosted its adoption for medical applications

Polytetrafluoroethylene (PTFE) is a highly versatile material known for its high durability and hydrophobic properties. PTFE offers a wide range of beneficial uses across numerous industries like automotive, construction, consumer goods, and healthcare, owing to their robust chemical and high-temperature resistance, low friction, thermal stability, and corrosion resistance.

Modern medicine makes extensive use of PTFE in several areas. With surging advancements in tissue engineering, the use of biomaterials in cardiovascular devices, small-diameter vascular grafts, sutures, catheters, and various other medical devices has increased significantly. Expanded polytetrafluoroethylene (ePTFE) has emerged as a highly reliable biomaterial for prosthetic vascular grafts, owing to its versatile properties, including robust flexibility and chemical inertness. PTFE is widely utilized in the treatment of chronic diseases, drug delivery, tissue regeneration, facial surgery, artificial organs, and diagnostic devices. Medical PTFE is available in various forms, including tubes, pastes, sheets, and fabric. Therefore, the surging usage of PTFE for the abovementioned purposes is projected to trigger the growth of the global medical polytetrafluoroethylene (PTFE) market in the coming years. The rising prevalence of chronic diseases, the burgeoning use of PTFE in making implantable prosthetic heart valve rings, the growing use of PTFE in dental implants, increasing periodontal disorders, and the increasing cardiovascular, neurovascular, and intravenous disorders are the other key factors boosting the demand for medical PTFE worldwide.

Read More: https://www.reportsanddata.com/report-detail/medical-polytetrafluoroethylene-ptfe-market  

Medical implantable devices are usually prone to infection, which puts patients’ lives on the line. However, PTFE grafts now come with anti-infective coatings like teicoplanin and gentamicin that help prevent the formation of biofilms on these grafts. Although PTFE finds widespread use in synthetic vascular surgeries, its use in small diameter vascular grafts was problematic because of the lack of its cellular interaction properties. The biological response to the implants was thus improved via specific technical methods, including glow discharge treatment and treatment with alkali metals. COVID-19 has impacted the healthcare industry in an unprecedented manner, dramatically increasing the demand for various medical devices and equipment, including the PPE (personal protective equipment), among frontline healthcare workers, as well as the common people, to contain the coronavirus’ spread. Therefore, PTFE’s effective use in making such equipment acts as a major driver for the global medical polytetrafluoroethylene (PTFE) market growth.

The global medical polytetrafluoroethylene (PTFE) market’s key competitors include Saint Gobain, Donaldson Company, W.L.Gore & Associates Inc., Chukoh Chemical Industries Ltd., Pall Corporation, Sumitomo Electric, and Markel, Zeus Inc. In July 2020, the leading South Korean wireless electronic device maker, Synopex, inked a merger deal with fluoropolymer manufacturer Flontec to extensively employ its advanced PTFE materials to make various medical equipment. In May 2020, the University of Pittsburgh introduced a high-performance, washable textile coating that efficiently prevents viruses, including the SARS-COV-2 virus (the virus that causes the COVID-19 illness), from sticking to fabric surfaces. The new virus-repellant fabric coating is made with PTFE and polypropylene microfibers that give it mechanical durability and wash stability.